Published

Tirzepatide Reduces Heart Failure Events in HFpEF With Obesity

Summary by Medscape
CHICAGO — A new study has shown for the first time that a drug therapy can reduce major heart failure
Think freely.Subscribe and get full access to Ground NewsSubscriptions start at $9.99/yearSubscribe

Bias Distribution

  • There is no tracked Bias information for the sources covering this story.
Factuality

To view factuality data please Upgrade to Premium

Ownership

To view ownership data please Upgrade to Vantage

Sources are mostly out of (0)